10/31/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:05 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
5:04 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
8:30 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
8:39 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/05/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
10:23 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:19 AM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
5:20 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:39 PM | Fink Jeffrey Arvin (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:41 PM | Higuchi John W. (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:43 PM | Jene Jill M. (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:45 PM | Lipocine (Issuer)
Ono Richard Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:48 PM | Lipocine (Issuer)
Papapetropoulos Spyros (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:32 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
4:15 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:03 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:06 AM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
5:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Lipocine (Filer)
| Form 424B5 | |
04/26/2024
4:20 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
11:15 PM | Lipocine (Filer)
| Form EFFECT | |
04/23/2024
3:24 PM | Lipocine (Filer)
| Form S-3/A | |
04/23/2024
3:05 PM | Lipocine (Filer)
| Form DEF 14A | |
04/11/2024
6:24 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
5:26 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
5:14 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
4:51 PM | Fogarty Krista (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:53 PM | Lipocine (Issuer)
Patel Mahesh V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:31 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
5:07 AM | Lipocine (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
5:08 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:01 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
7:20 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
12/19/2023
9:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:15 PM | Lipocine (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2023
1:45 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
12:15 PM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
8:50 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
